Solventum

Solventum is a healthcare company spun off from 3M in 2024, comprising medical products such as wound care, dental solutions, health information systems and purification technologies. As a young standalone business, it is working to sharpen its portfolio and improve growth after operating for years inside a larger industrial parent. As a recent spin-off, Solventum has not established a dividend track record and its payout policy remains uncertain while it addresses debt and separation costs. Any income potential is unproven, and the shares are better understood as a turnaround and restructuring story. The profile is that of a transitional business rather than a settled dividend payer.